EHJ Editor-in-Chief/X
Aug 7, 2025, 05:52
Early Heparin in STEMI Care? EHJ Publishes Results of the Groundbreaking HELP-PCI Trial
EHJ Editor-in-Chief (Filippo Crea) posted on X:
”Could administering heparin at first medical contact improve outcomes in STEMI treatment? Read the results of HELP-PCI trial in EHJ.”
Read the full article here.
The HELP-PCI trial studied 999 STEMI patients undergoing PPCI to compare the timing of UFH administration—at first medical contact (FMC) vs in the Cath Lab.
Patients who received UFH at FMC had significantly better initial coronary blood flow (TFG-3: 23.6% vs 17.6%; OR 1.44; P = .02).
No differences were seen in 12-month MACCE, reperfusion success, or major bleeding.
Early UFH may improve pre-PPCI perfusion without added risk.
Stay updated on the latest scientific advances with Hemostasis Today.
-
Jul 22, 2026, 06:59Martina Böhm-Weigert: Supporting Precision Dosing in Hemophilia with Fitusiran
-
Jul 22, 2026, 05:26Richard Dalyai: Can AI Safely Refill Medications?
-
Jul 22, 2026, 05:15Annie Bauzon: What Is Anemia? – Microcytic, Normocytic and Macrocytic Types Explained
-
Jul 22, 2026, 05:05Rob Maloney: What If Hemophilia No Longer Needed Lifelong Treatment?
-
Jul 22, 2026, 05:01Melina Rodriguez: First FDA-Approved VWD Prophylaxis for All Ages
-
Jul 22, 2026, 04:59Martina Wolff: Advancing Knowledge Through Global Collaboration at ISTH 2026
-
Jul 22, 2026, 04:52G. Shellye Horowitz: Hemophilia A Genetics – Hemophilia A and Pregnancy
-
Jul 21, 2026, 23:43Shadi Tabibian: The Clinical Power of Patient Stories in Rare Bleeding Disorders
-
Jul 21, 2026, 23:35Pete Stibbs: Impressed with PE Compass and Clinical Compass from Mona Ranade and Team